Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

Abroad (travel likely)RecruitingPHASE3

Conditions

Myasthenia Gravis, Generalized

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Policlinico A. Gemelli IRCCS, Roma, Italy
Contact: Study coordinator (Raffaele Iorio) · raffaele.iorio@policlinicogemelli.it · +393347185128

Study leads

Raffaele Iorio
Principal Investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE3

Fayetteville, United States

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE2

Boca Raton, United States · Boca Raton, United States

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE1, PHASE2

Altamonte Springs, United States · Boca Raton, United States

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis · Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Los Angeles, United States · Orange, United States